Cargando…
Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457759/ https://www.ncbi.nlm.nih.gov/pubmed/34580665 http://dx.doi.org/10.1016/S2666-7568(21)00230-0 |
| _version_ | 1784571172232364032 |
|---|---|
| author | Lefèvre, Benjamin Tondeur, Laura Madec, Yoann Grant, Rebecca Lina, Bruno van der Werf, Sylvie Rabaud, Christian Fontanet, Arnaud |
| author_facet | Lefèvre, Benjamin Tondeur, Laura Madec, Yoann Grant, Rebecca Lina, Bruno van der Werf, Sylvie Rabaud, Christian Fontanet, Arnaud |
| author_sort | Lefèvre, Benjamin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8457759 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84577592021-09-23 Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France Lefèvre, Benjamin Tondeur, Laura Madec, Yoann Grant, Rebecca Lina, Bruno van der Werf, Sylvie Rabaud, Christian Fontanet, Arnaud Lancet Healthy Longev Comment The Author(s). Published by Elsevier Ltd. 2021-11 2021-09-22 /pmc/articles/PMC8457759/ /pubmed/34580665 http://dx.doi.org/10.1016/S2666-7568(21)00230-0 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Lefèvre, Benjamin Tondeur, Laura Madec, Yoann Grant, Rebecca Lina, Bruno van der Werf, Sylvie Rabaud, Christian Fontanet, Arnaud Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France |
| title | Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France |
| title_full | Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France |
| title_fullStr | Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France |
| title_full_unstemmed | Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France |
| title_short | Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France |
| title_sort | beta sars-cov-2 variant and bnt162b2 vaccine effectiveness in long-term care facilities in france |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457759/ https://www.ncbi.nlm.nih.gov/pubmed/34580665 http://dx.doi.org/10.1016/S2666-7568(21)00230-0 |
| work_keys_str_mv | AT lefevrebenjamin betasarscov2variantandbnt162b2vaccineeffectivenessinlongtermcarefacilitiesinfrance AT tondeurlaura betasarscov2variantandbnt162b2vaccineeffectivenessinlongtermcarefacilitiesinfrance AT madecyoann betasarscov2variantandbnt162b2vaccineeffectivenessinlongtermcarefacilitiesinfrance AT grantrebecca betasarscov2variantandbnt162b2vaccineeffectivenessinlongtermcarefacilitiesinfrance AT linabruno betasarscov2variantandbnt162b2vaccineeffectivenessinlongtermcarefacilitiesinfrance AT vanderwerfsylvie betasarscov2variantandbnt162b2vaccineeffectivenessinlongtermcarefacilitiesinfrance AT rabaudchristian betasarscov2variantandbnt162b2vaccineeffectivenessinlongtermcarefacilitiesinfrance AT fontanetarnaud betasarscov2variantandbnt162b2vaccineeffectivenessinlongtermcarefacilitiesinfrance |